Francois-Xavier Pellay, PhD
A scientist and entrepreneur in the longevity industry, with a multidisciplinary background that includes a Master's degree in Biochemistry, a Master's degree in Organic Chemistry, a PhD in Bioinformatics, and years of research experience across Microbiology, Molecular Biology, Cellular Biology and the Biology of Aging.
His research focuses on the discovery of new longevity molecules that can slow down or reverse the aging process, with both medical and wellbeing applications. He also holds extensive expertise in omics science, including transcriptomics, genomics and microbiomics.
Over the past four years he has created several longevity companies, including a skin rejuvenation company, a longevity supplement company, and two biotech companies oriented toward the discovery of longevity drugs and their application to age-related diseases.
He serves as consultant and scientific board member for companies across the longevity industry, from digital health platforms to longevity clinics.
